Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetics of symptom remission in outpatients with COVID-19.
Dubé MP, Lemaçon A, Barhdadi A, Lemieux Perreault LP, Oussaïd E, Asselin G, Provost S, Sun M, Sandoval J, Legault MA, Mongrain I, Dubois A, Valois D, Dedelis E, Lousky J, Choi J, Goulet E, Savard C, Chicoine LM, Cossette M, Chabot-Blanchet M, Guertin MC, de Denus S, Bouabdallaoui N, Marchand R, Bassevitch Z, Nozza A, Gaudet D, L'Allier PL, Hussin J, Boivin G, Busseuil D, Tardif JC. Dubé MP, et al. Among authors: busseuil d. Sci Rep. 2021 May 25;11(1):10847. doi: 10.1038/s41598-021-90365-6. Sci Rep. 2021. PMID: 34035401 Free PMC article. Clinical Trial.
Colchicine: an old wine in a new bottle?
Roubille F, Kritikou E, Busseuil D, Barrere-Lemaire S, Tardif JC. Roubille F, et al. Among authors: busseuil d. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):14-23. doi: 10.2174/1871523011312010004. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286287 Review.
Cardiac consequences of anti-inflammatory drugs in experimental models.
Merlet N, Busseuil D, Rhéaume É, Tardif JC. Merlet N, et al. Among authors: busseuil d. Antiinflamm Antiallergy Agents Med Chem. 2013;12(1):24-35. doi: 10.2174/1871523011312010005. Antiinflamm Antiallergy Agents Med Chem. 2013. PMID: 23286290 Review.
Investigational drugs targeting cardiac fibrosis.
Roubille F, Busseuil D, Merlet N, Kritikou EA, Rhéaume E, Tardif JC. Roubille F, et al. Among authors: busseuil d. Expert Rev Cardiovasc Ther. 2014 Jan;12(1):111-25. doi: 10.1586/14779072.2013.839942. Epub 2013 Dec 18. Expert Rev Cardiovasc Ther. 2014. PMID: 24218990 Review.
The interleukin-1β modulator gevokizumab reduces neointimal proliferation and improves reendothelialization in a rat carotid denudation model.
Roubille F, Busseuil D, Shi Y, Nachar W, Mihalache-Avram T, Mecteau M, Gillis MA, Brand G, Théberge-Julien G, Brodeur MR, Kernaleguen AE, Gombos M, Rhéaume E, Tardif JC. Roubille F, et al. Among authors: busseuil d. Atherosclerosis. 2014 Oct;236(2):277-85. doi: 10.1016/j.atherosclerosis.2014.07.012. Epub 2014 Jul 21. Atherosclerosis. 2014. PMID: 25108619
59 results